Brief: DRI Healthcare Trust Announces Acquisition Of A Royalty Interest In Zejula

DRI Healthcare Trust

12/09/2022 12:47

Sept 12 (Reuters) - DRI Healthcare Trust  DHT_u.TO :
    * DRI HEALTHCARE TRUST ANNOUNCES ACQUISITION OF A ROYALTY
INTEREST
IN ZEJULA®, CURRENTLY APPROVED FOR THE TREATMENT OF OVARIAN
CANCER WITH ADDITIONAL INDICATIONS UNDER DEVELOPMENT
    * DRI HEALTHCARE TRUST - TRANSACTION ENTITLES DRI TO A NET
0.5%
ROYALTY ON WORLDWIDE NET SALES OF ZEJULA BY GSK PLC
    * DRI HEALTHCARE - TO BE ENTITLED TO RECEIVE QTRLY ROYALTY
PAYMENTS ON ONE-QUARTER LAG BASED ON SALES FROM JULY 1, 2022, TO
GET FIRST PAYMENT IN Q4 2022
    * DRI HEALTHCARE TRUST - ROYALTY TERM IS EXPECTED TO
CONTINUE FOR
AT LEAST ANOTHER 10 YEARS WORLDWIDE

Source text for Eikon:  ID:nCNWhvbhQa 
Further company coverage:  DHT_u.TO 

 ((Reuters.Briefs@thomsonreuters.com;))